MedTrace Logo

Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients

NCT07418242 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1491

Last updated 2026-05-18

No results posted yet for this study

Summary

This project aims to detect novel biomarkers from preoperative and early postoperative serum and urine samples of patients to screen and analyze the risk factors for predicting adverse postoperative renal outcomes in high-risk patients in cardiac surgery.

Conditions

  • Cardiac Surgery Associated - Acute Kidney Injury
  • Critical Illness

Interventions

OTHER

Standard care "bundle"

The management for AKI patients were performed by implementing a standard care "bundle" suggested by the Kidney Disease Improving Global Outcome (KDIGO) guideline.

Sponsors & Collaborators

  • Guowei Tu

    lead OTHER

Principal Investigators

  • Zhe Luo, MD · Fudan University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-23
Primary Completion
2028-12-31
Completion
2029-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07418242 on ClinicalTrials.gov